Hybrid Modeling

Accelerating and Improving Bioprocess Development with Machine Learning Solutions

Michael Sokolov, Ph.D.; Alessandro Butté, Ph.D.

DataHow

Pharmacovigilance

Navigating Shifting Requirements and an Explosion of Data in Pharmacovigilance

Sally Amanuel

PrimeVigilance

Neurology

The Next Frontier in Neurological Diagnostics and Therapeutics

Dave Rosa

NeuroOne

Clinical Trials

Optimizing Oncology and Rare Disease Clinical Trials by Focusing on Science and Aligning with both Patients and Investigators

Dave Selkirk

Ergomed

IND, NDA, and BLA

Building a Regulatory Roadmap for IND, NDA, and BLA

Rebecca Lamb-Wharton, Ph.D.; Brenda Schlenk, RPh; Mamadou Diallo, PharmD

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Viral Vectors

A Viral Vector CDMO Vision that Resonates

Drew Brennan; Chris Berger; Elie Hanania, Ph.D.; Dave Ingamells; Rami Barghout, PE

Avid Bioservices

Digital Pathology

Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform

Nathan Buchbinder

Proscia

3D Printing

Exploring New Possibilities with 3D Printing of Pharmaceuticals

Thomas Kipping, Ph.D.

MilliporeSigma

Translation

The Translational Index Score: Improving the Entire Drug Development Cycle

Jo Varshney, Ph.D., D.V.M.

Robotic Sterile Fill-Finish

Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services

Peter Kim; Jerome Detreille; Derek Truninger

New Packaging

Consistent Formulation, Continuous Improvement: Introducing Robust, Easier-to-Use Detergent Packaging

Michael Moussourakis

Alconox Inc.

Cell Culture Media

Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products

Thomas Yezzi

Nu-Tek BioSciences

Vaccines

Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines

David Dodd; Mark Newman, Ph.D.

GeoVax Inc.

Biotherapeutics

Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO

John R. Mosack

Tanvex CDMO

3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.

Corning Life Sciences

Cell Therapy

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

Sarah Meeks, Ph.D.

MaxCyte

Cell Therapy

Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies

Beau Webber, Ph.D.

Luminary Therapeutics

Viscosity Reduction

Viscosity Reduction with An Excipient Platform and Feasibility Testing Service

Alana Gouveia

MilliporeSigma

Quality Culture

Does Your Biologics CDMO Truly Have a Culture of Quality?

Joe Payne

Scorpius BioManufacturing